1. Home
  2. ETON vs MAGN Comparison

ETON vs MAGN Comparison

Compare ETON & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • MAGN
  • Stock Information
  • Founded
  • ETON 2017
  • MAGN 1864
  • Country
  • ETON United States
  • MAGN United States
  • Employees
  • ETON N/A
  • MAGN N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • MAGN Paper
  • Sector
  • ETON Health Care
  • MAGN Basic Materials
  • Exchange
  • ETON Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • ETON 498.8M
  • MAGN 416.2M
  • IPO Year
  • ETON 2018
  • MAGN N/A
  • Fundamental
  • Price
  • ETON $16.95
  • MAGN $9.04
  • Analyst Decision
  • ETON Strong Buy
  • MAGN Hold
  • Analyst Count
  • ETON 3
  • MAGN 1
  • Target Price
  • ETON $29.67
  • MAGN $12.00
  • AVG Volume (30 Days)
  • ETON 278.7K
  • MAGN 586.6K
  • Earning Date
  • ETON 11-06-2025
  • MAGN 11-20-2025
  • Dividend Yield
  • ETON N/A
  • MAGN N/A
  • EPS Growth
  • ETON N/A
  • MAGN N/A
  • EPS
  • ETON N/A
  • MAGN N/A
  • Revenue
  • ETON $70,316,000.00
  • MAGN $2,919,000,000.00
  • Revenue This Year
  • ETON $105.25
  • MAGN $49.20
  • Revenue Next Year
  • ETON $40.84
  • MAGN $5.03
  • P/E Ratio
  • ETON N/A
  • MAGN N/A
  • Revenue Growth
  • ETON 102.77
  • MAGN 34.21
  • 52 Week Low
  • ETON $8.43
  • MAGN $8.40
  • 52 Week High
  • ETON $23.00
  • MAGN $23.19
  • Technical
  • Relative Strength Index (RSI)
  • ETON 38.74
  • MAGN 44.41
  • Support Level
  • ETON $16.34
  • MAGN $8.80
  • Resistance Level
  • ETON $18.15
  • MAGN $9.11
  • Average True Range (ATR)
  • ETON 1.08
  • MAGN 0.41
  • MACD
  • ETON -0.14
  • MAGN 0.12
  • Stochastic Oscillator
  • ETON 14.34
  • MAGN 56.77

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: